Skip to main content
Full access
Perspectives
Published Online: 1 December 2012

Diffusion Tensor Imaging and Mild Traumatic Brain Injury in Soldiers: Abnormal Findings, Uncertain Implications

Each year in the United States, approximately 1–2 million people sustain a traumatic brain injury (TBI), making this the second most common neurological disorder after headaches (1, 2). Approximately 80% are mild TBIs, which are those injuries where the Glasgow Coma Scale score is greater than 13, loss of consciousness is less than 30 minutes, posttraumatic amnesia is less than 24 hours, or even a brief alteration of mental state (“dazed and confused”) occurs (3, 4). Over the past 5–10 years, interest in mild TBI has been increasing because of sports concussions and injuries among U.S. military and civilian personnel serving in Iraq and Afghanistan. An estimated 15%–20% of soldiers sustain mild TBIs during their deployment in these theaters (1, 5).
Routine neuroimaging techniques (CT and MRI) do not usually reveal abnormalities after mild TBI, so extensive research is being conducted to find methods with greater sensitivity and specificity. White matter tracts such as the corpus callosum, internal capsule, and corona radiata appear to be the most vulnerable to injury. Diffusion tensor imaging (DTI) is able to detect damage to axonal tracts by using a measure of directional water diffusion (fractional anisotropy). Both positive and negative findings have been reported (2, 6). Some studies analyzed whole brain areas while others focused on specific regions of interest. Unfortunately, there has been no methodological uniformity among studies in defining abnormality. Since abnormalities are often calculated based on differences from healthy comparison subjects, the question arises as to what is the most appropriate control. As individuals with mild TBI may also have posttraumatic stress disorder (PTSD), depression, anxiety, headaches, sleep disturbance, and other symptoms, researchers need to compare individuals with TBI with those who have psychiatric symptoms but no injury. A recent study found DTI abnormalities in combat-exposed soldiers, which normalized after 1.5 years, but the soldiers had neither PTSD nor TBI (7).
In a recent meta-analysis, Aoki et al. (8) analyzed 13 studies of mild TBI that met specific criteria. They found significant reductions in fractional anisotropy in the posterior portions of the corpus callosum (the splenium). As a comparison, Lipton et al. (9) performed DTI 2 weeks, 3 months, and 6 months after injury in 34 patients with mild TBI and 30 matched healthy comparison subjects. They found varied patterns of white matter abnormalities in the TBI patients over time. At 2 weeks, areas of both low and high fractional anisotropy were found in 32 patients in the corona radiata, the precentral white matter, the internal capsule, and the deep and subcortical white matter. These patients had low fractional anisotropy in the splenium of the corpus callosum, but high fractional anisotropy in the anterior corpus callosum (genu and body). Only six had high fractional anisotropy in the splenium. At 3 months, most patients had more areas of high fractional anisotropy and fewer low areas. By 6 months, 10/10 patients had areas of high fractional anisotropy, while 7/10 had areas of low fractional anisotropy (a pattern of decline of low areas over time). This demonstrates that patterns of abnormalities differ among patients and over time. This finding complicates the analyses of studies that “average” abnormal areas and meta-analyses of multiple studies.
The study by Jorge et al. (10) in this issue provides an additional method of analyzing DTI data and examines whether specific regions of interest or the number of abnormal areas is the most sensitive method. The authors hypothesized that lesions may occur in different areas, depending on the injury and the individual, and thus that restricting analysis to specific regions may overlook significant pathology. They studied returning veterans of the wars in Iraq and Afghanistan and examined 72 individuals with mild TBI from blast exposure (32 of these veterans also had acceleration and rotational forces), 21 veterans without TBI, and 14 civilians with TBI who did not have any psychopathology. They analyzed DTI with a voxel-based analysis and a method to detect spatially heterogeneous areas of decreased fractional anisotropy (“potholes”). MRI was obtained within 90 days of trauma for civilians and approximately 50 months for the military groups. Individuals were assessed for psychiatric diagnosis (including ratings for PTSD and depression) and for executive function and memory. Average voxel-based fractional anisotropy failed to reveal differences among these groups; however, there was a difference in the number of potholes detected in veterans with TBI relative to those without. While the mild TBI veteran group had more potholes than the veterans without TBI, the civilian TBI group had more potholes than the military TBI groups. The authors did not examine whether there were fewer potholes in the veterans who had only blast injury. The number of potholes was associated with TBI severity, and a negative correlation was observed between the number of potholes in the corpus callosum and executive functioning. Psychiatric disorders and symptoms were not related to the number of potholes.
These findings are intriguing and promising, and they need replication. Jorge et al. are to be congratulated for including an appropriate comparison group that had similar psychiatric problems but did not experience mild TBI, in addition to a civilian group with mild TBI. The study’s strength is that it examines DTI data in a different way (which emphasizes the fact that we have no accepted consensus as to the best way to do this). The weakness is that this study cannot be viewed as a study of blast injury, but rather a study of abnormalities in soldiers who have had mild TBI and emotional problems. At this time, we need to view the potholes as an unproven possible pathophysiological signature that may be an epiphenomenon of what we are calling a brain injury. We do not know the prognostic significance of an abnormality, and it appears that the abnormalities may change over time.
While the authors did not advocate the use of potholes as a diagnostic biomarker for TBI, clinicians must be cautious and not indiscriminately apply an invaluable research technique to the many individuals who have suffered a concussion, especially in forensic settings. Before using DTI in patients with suspected mild TBI, consider this scenario: You had a concussion 6 months ago, and still don’t feel right. You are slower to process things and have trouble multitasking. You tire easily and are irritable. Routine brain imaging results have been normal. Your doctor orders a 3-T MRI with DTI that reveals white matter lesions consistent with a TBI. Does this finding make you feel better or worse? Does the belief that a brain injury has been confirmed provide relief (a cause has been found, and it’s not “in my head”), or distress (there is brain damage, and I won’t get better)? Does this help or interfere with recovery?
The vast majority of individuals with a single concussion fully recover. The evidence indicates that a positive expectation of recovery significantly predicts prognosis (11), and many unexplored factors may influence symptoms and recovery (12). Will the finding of an abnormality on DTI—which has no bearing on treatment decisions or interventions, since those are symptom based—affect recovery? Studies such as the one by Jorge et al. are important steps forward in trying to understand possible pathological changes, because they control for common coexisting problems. Unfortunately, these studies do not yet provide us with a gold-standard clinical diagnostic measure for TBI.

References

1.
Tanielian T, Jaycox LH: Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery. Santa Monica, Calif, RAND Corporation, 2008
2.
Mac Donald CL, Johnson AM, Cooper D, Nelson EC, Werner NJ, Shimony JS, Snyder AZ, Raichle ME, Witherow JR, Fang R, Flaherty SF, Brody DL: Detection of blast-related traumatic brain injury in US military personnel. N Engl J Med 2011; 364:2091–2100
3.
Marr AL, Coronado VG: Central Nervous System Injury Surveillance Data Submission Standards: 2002. Atlanta, Center for Disease Control and Prevention, National Center for Injury Prevention and Control, 2002
4.
Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE: Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 1999; 14:602–615
5.
Warden D: Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil 2006; 21:398–402
6.
Levin HS, Wilde E, Troyanskaya M, Petersen NJ, Scheibel R, Newsome M, Radaideh M, Wu T, Yallampalli R, Chu Z, Li X: Diffusion tensor imaging of mild to moderate blast-related traumatic brain injury and its sequelae. J Neurotrauma 2010; 27:683–694
7.
van Wingen GA, Geuze E, Caan MWA, Kozicz T, Olabarriaga SD, Denys D, Vermetten E, Fernández G: Persistent and reversible consequences of combat stress on the mesofrontal circuit and cognition. Proc Natl Acad Sci USA 2012; 109:15508–15513
8.
Aoki Y, Inokuchi R, Gunshin M, Yahagi N, Suwa H: Diffusion tensor imaging studies of mild traumatic brain injury: a meta-analysis. J Neurol Neurosurg Psychiatry 2012; 83:870–876
9.
Lipton ML, Kim N, Park YK, Hulkower MB, Gardin TM, Shifteh K, Kim M, Zimmerman ME, Lipton RB, Branch CA: Robust detection of traumatic axonal injury in individual mild traumatic brain injury patients: intersubject variation, change over time, and bidirectional changes in anisotropy. Brain Imaging Behav 2012; 6:329–342
10.
Jorge RE, Acion L, White W, Tordesillas-Gutierrez D, Pierson R, Crespo-Facorro B, Magnotta VA: White matter abnormalities in veterans with mild traumatic brain injury. Am J Psychiatry 2012; 169:1284–1291
11.
Hou R, Moss-Morris R, Peveler R, Mogg K, Bradley BP, Belli A: When a minor head injury results in enduring symptoms: a prospective investigation of risk factors for postconcussional syndrome after mild traumatic brain injury. J Neurol Neurosurg Psychiatry 2012; 6:329–342
12.
Silver JM: Effort, exaggeration and malingering after concussion. J Neurol Neurosurg Psychiatry 2012; 83:836–841

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1230 - 1232
PubMed: 23212052

History

Accepted: September 2012
Published online: 1 December 2012
Published in print: December 2012

Authors

Details

Jonathan M. Silver, M.D.
From the Department of Psychiatry, New York University School of Medicine, New York.

Notes

Address correspondence to Dr. Silver ([email protected]).

Competing Interests

Dr. Silver has served on an advisory panel for Eli Lilly and as associate editor for Journal Watch Psychiatry and Up To Date. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share